Konstantinos Kyriakidis Selected Research

1- (1- methylethyl)- 4- ((1- (6- (trifluoromethyl)- 3- pyridinyl)- 4- piperidinyl)carbonyl)hexahydro- 1H- 1,4- diazepine

1/2015

Histamine H3 and H4 receptor ligands modify vascular histamine levels in normal and arthritic large blood vessels in vivo.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Konstantinos Kyriakidis Research Topics

Disease

1	Inflammation (Inflammations) 01/2015
1	Arthritis (Polyarthritis) 01/2015
1	Neuralgia (Stump Neuralgia) 12/2011
1	Parkinson Disease (Parkinson's Disease) 12/2011
1	Schizophrenia (Dementia Praecox) 12/2011
1	Sleep Wake Disorders 12/2011
1	Cognitive Dysfunction 12/2011
1	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 12/2011
1	Central Nervous System Diseases (CNS Diseases) 12/2011
1	Narcolepsy 12/2011

Drug/Important Bio-Agent (IBA)

2	Histamine (Histamine Dihydrochloride)FDA Link 01/2015 - 12/2011
1	Histamine H4 ReceptorsIBA 01/2015
1	Histamine H3 Receptors (Histamine H3 Receptor)IBA 01/2015
1	1- (1- methylethyl)- 4- ((1- (6- (trifluoromethyl)- 3- pyridinyl)- 4- piperidinyl)carbonyl)hexahydro- 1H- 1,4- diazepineIBA 01/2015
1	Pharmaceutical PreparationsIBA 12/2011
1	LigandsIBA 12/2011